A detailed history of Spirepoint Private Client, LLC transactions in Amgen Inc stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 4,083 shares of AMGN stock, worth $1.29 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,083
Previous 3,903 4.61%
Holding current value
$1.29 Million
Previous $1.11 Billion 14.96%
% of portfolio
0.18%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $47,295 - $57,475
180 Added 4.61%
4,083 $1.28 Billion
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $1.05 Million - $1.27 Million
3,903 New
3,903 $1.11 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.